148 related articles for article (PubMed ID: 26147015)
21. Upregulation of the endothelin A (ET
McGrady NR; Minton AZ; Stankowska DL; He S; Jefferies HB; Krishnamoorthy RR
BMC Neurosci; 2017 Mar; 18(1):27. PubMed ID: 28249604
[TBL] [Abstract][Full Text] [Related]
22. An acute intraocular pressure challenge to assess retinal ganglion cell injury and recovery in the mouse.
Crowston JG; Kong YX; Trounce IA; Dang TM; Fahy ET; Bui BV; Morrison JC; Chrysostomou V
Exp Eye Res; 2015 Dec; 141():3-8. PubMed ID: 25753840
[TBL] [Abstract][Full Text] [Related]
23. Progressive degeneration of retinal and superior collicular functions in mice with sustained ocular hypertension.
Chen H; Zhao Y; Liu M; Feng L; Puyang Z; Yi J; Liang P; Zhang HF; Cang J; Troy JB; Liu X
Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1971-84. PubMed ID: 25722210
[TBL] [Abstract][Full Text] [Related]
24. A Dietary Combination of Forskolin with Homotaurine, Spearmint and B Vitamins Protects Injured Retinal Ganglion Cells in a Rodent Model of Hypertensive Glaucoma.
Cammalleri M; Dal Monte M; Amato R; Bagnoli P; Rusciano D
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32340314
[TBL] [Abstract][Full Text] [Related]
25. The non-human primate experimental glaucoma model.
Burgoyne CF
Exp Eye Res; 2015 Dec; 141():57-73. PubMed ID: 26070984
[TBL] [Abstract][Full Text] [Related]
26. Laser-Induced Ocular Hypertension in a Mouse Model of Glaucoma.
Ramírez JM; Salobrar-García E; de Hoz R; Salazar JJ; Matamoros JA; Sánchez-Puebla L; López-Cuenca I; Fernández-Albarral JA; Ramírez AI
Methods Mol Biol; 2023; 2708():49-56. PubMed ID: 37558959
[TBL] [Abstract][Full Text] [Related]
27. Cumulative mtDNA damage and mutations contribute to the progressive loss of RGCs in a rat model of glaucoma.
Wu JH; Zhang SH; Nickerson JM; Gao FJ; Sun Z; Chen XY; Zhang SJ; Gao F; Chen JY; Luo Y; Wang Y; Sun XH
Neurobiol Dis; 2015 Feb; 74():167-179. PubMed ID: 25478814
[TBL] [Abstract][Full Text] [Related]
28. Silicone oil-induced ocular hypertension and glaucomatous neurodegeneration in mouse.
Zhang J; Li L; Huang H; Fang F; Webber HC; Zhuang P; Liu L; Dalal R; Tang PH; Mahajan VB; Sun Y; Li S; Zhang M; Goldberg JL; Hu Y
Elife; 2019 May; 8():. PubMed ID: 31090540
[TBL] [Abstract][Full Text] [Related]
29. Etanercept, a widely used inhibitor of tumor necrosis factor-α (TNF-α), prevents retinal ganglion cell loss in a rat model of glaucoma.
Roh M; Zhang Y; Murakami Y; Thanos A; Lee SC; Vavvas DG; Benowitz LI; Miller JW
PLoS One; 2012; 7(7):e40065. PubMed ID: 22802951
[TBL] [Abstract][Full Text] [Related]
30. [Progress of chronic ocular hypertensive glaucoma in rodents].
Liu LF; Zhang MZ
Zhonghua Yan Ke Za Zhi; 2009 Jul; 45(7):663-8. PubMed ID: 19957696
[TBL] [Abstract][Full Text] [Related]
31. Endothelin B receptors contribute to retinal ganglion cell loss in a rat model of glaucoma.
Minton AZ; Phatak NR; Stankowska DL; He S; Ma HY; Mueller BH; Jiang M; Luedtke R; Yang S; Brownlee C; Krishnamoorthy RR
PLoS One; 2012; 7(8):e43199. PubMed ID: 22916224
[TBL] [Abstract][Full Text] [Related]
32. Gene and protein expression pilot profiling and biomarkers in an experimental mouse model of hypertensive glaucoma.
Walsh MM; Yi H; Friedman J; Cho KI; Tserentsoodol N; McKinnon S; Searle K; Yeh A; Ferreira PA
Exp Biol Med (Maywood); 2009 Aug; 234(8):918-30. PubMed ID: 19491369
[TBL] [Abstract][Full Text] [Related]
33. Mouse model of ocular hypertension with retinal ganglion cell degeneration.
Mukai R; Park DH; Okunuki Y; Hasegawa E; Klokman G; Kim CB; Krishnan A; Gregory-Ksander M; Husain D; Miller JW; Connor KM
PLoS One; 2019; 14(1):e0208713. PubMed ID: 30640920
[TBL] [Abstract][Full Text] [Related]
34. Time-dependent retinal ganglion cell loss, microglial activation and blood-retina-barrier tightness in an acute model of ocular hypertension.
Trost A; Motloch K; Bruckner D; Schroedl F; Bogner B; Kaser-Eichberger A; Runge C; Strohmaier C; Klein B; Aigner L; Reitsamer HA
Exp Eye Res; 2015 Jul; 136():59-71. PubMed ID: 26001526
[TBL] [Abstract][Full Text] [Related]
35. Rodent models of glaucoma.
Johnson TV; Tomarev SI
Brain Res Bull; 2010 Feb; 81(2-3):349-58. PubMed ID: 19379796
[TBL] [Abstract][Full Text] [Related]
36. Immune response after intermittent minimally invasive intraocular pressure elevations in an experimental animal model of glaucoma.
Gramlich OW; Teister J; Neumann M; Tao X; Beck S; von Pein HD; Pfeiffer N; Grus FH
J Neuroinflammation; 2016 Apr; 13(1):82. PubMed ID: 27090083
[TBL] [Abstract][Full Text] [Related]
37. Enriched environment provides neuroprotection against experimental glaucoma.
González Fleitas MF; Devouassoux JD; Aranda ML; Calanni JS; Chianelli MS; Dorfman D; Rosenstein RE
J Neurochem; 2020 Jan; 152(1):103-121. PubMed ID: 31587281
[TBL] [Abstract][Full Text] [Related]
38. CXCR3 antagonism of SDF-1(5-67) restores trabecular function and prevents retinal neurodegeneration in a rat model of ocular hypertension.
Denoyer A; Godefroy D; Célérier I; Frugier J; Degardin J; Harrison JK; Brignole-Baudouin F; Picaud S; Baleux F; Sahel JA; Rostène W; Baudouin C
PLoS One; 2012; 7(6):e37873. PubMed ID: 22675496
[TBL] [Abstract][Full Text] [Related]
39. Peptains block retinal ganglion cell death in animal models of ocular hypertension: implications for neuroprotection in glaucoma.
Nam MH; Stankowska DL; Johnson GA; Nahomi RB; Pantcheva MB; Nagaraj RH
Cell Death Dis; 2022 Nov; 13(11):958. PubMed ID: 36379926
[TBL] [Abstract][Full Text] [Related]
40. Involvement of EphB/Ephrin-B signaling in axonal survival in mouse experimental glaucoma.
Fu CT; Sretavan D
Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):76-84. PubMed ID: 22064993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
